Trial · NCT07853274
Dose-Response Effects of Short-Term Ashwagandha on Anaerobic Exercise and Cognitive Function in Resistance-Trained Athletes
NCT07853274, Not applicable, Completed, Jacksonville State University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Dose-Response Effects of Short-Term Ashwagandha on Anaerobic Exercise and Cognitive Function in Resistance-Trained Athletes. Trials, record NCT07853274. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07853274
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Dose-Response Effects of Short-Term Ashwagandha on Anaerobic Exercise and Cognitive Function in Resistance-Trained Athletes
- NCT number
- NCT07853274
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 23 participants, actual
- Lead sponsor
- Jacksonville State University
- Conditions
- Resistance Exercise Performance, Cognitive Functions, Anaerobic Performance, Dietary Supplementation Athletic Performance
- Interventions
- Low-dose Ashwagandha Supplement, High-dose Ashwagandha Supplement, Maltodextrin (Placebo)
- First posted
- 2026-10-01
- Last updated
- 2026-10-01
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Resistance Exercise Performance | Baseline and after each of three seven-day supplementation periods, with seven-day washouts between conditions; total duration approximately five weeks. | Outcome measures comprised bench press and leg press one-repetition maximum (1RM), total lifting volume (sets × reps × weight), and Tendo-derived peak and mean barbell power during the bench press. These variables were assessed at four time points within a crossover design incorporating a one-week supplementation phase and a one-week washout phase, with each outcome reported in its corresponding unit (kilograms for 1RM and volume; watts for power). |
| Primary | Anaerobic Exercise Performance | Baseline, end of Week 1 (post-supplementation), end of Week 2 (post-washout), and end of Week 3 (post-crossover supplementation) | Peak power, mean power, and total work were measured via the 30-second Wingate Anaerobic Test. Assessed at 4 time points across a crossover design (1-week supplementation, 1-week washout). Each measure was reported separately in its respective unit (watts for peak and mean power; joules for total work). |
| Secondary | Cognitive Function | Baseline, end of Week 1 (post-supplementation), end of Week 2 (post-washout), and end of Week 3 (post-crossover supplementation). | Cognitive performance was assessed using the Stroop Color-Word Test, measuring selective attention, cognitive flexibility, and processing speed. Assessed at 4 time points across a crossover design (1-week supplementation, 1-week washout). |
| Secondary | Rating of Perceived Exertion (RPE) | Baseline, end of Week 1 (post-supplementation), end of Week 2 (post-washout), and end of Week 3 (post-crossover supplementation) | Perceived exertion was recorded using the Borg 6-20 scale at 1 minute post-bench press and post-leg press. Assessed at 4 time points across a crossover design (1-week supplementation, 1-week washout). |
| Secondary | Heart Rate (HR) | Baseline, end of Week 1 (post-supplementation), end of Week 2 (post-washout), and end of Week 3 (post-crossover supplementation) | Resting and post-exercise heart rates were recorded at rest and 1 minute after the bench press, leg press, and Wingate test. Assessed at 4 time points across a crossover design (1-week supplementation, 1-week washout). Unit of Measure: beats per minute (bpm) |
| Secondary | Systolic Blood Pressure (SBP) | Baseline, end of Week 1 (post-supplementation), end of Week 2 (post-washout), and end of Week 3 (post-crossover supplementation) | Resting and post-exercise systolic blood pressure were recorded at rest and 1 minute after the bench press, leg press, and Wingate test. Assessed at 4 time points across a crossover design (1-week supplementation, 1-week washout). Unit of Measure: mmHg |
| Secondary | Diastolic Blood Pressure (DBP) | Baseline, end of Week 1 (post-supplementation), end of Week 2 (post-washout), and end of Week 3 (post-crossover supplementation) | Resting and post-exercise diastolic blood pressure were recorded at rest and 1 minute after the bench press, leg press, and Wingate test. Assessed at 4 time points across a crossover design (1-week supplementation, 1-week washout). Unit of Measure: mmHg |
| Secondary | Tolerability and Adverse Events | During each of the 3 supplementation weeks: Week 1, Week 2, and Week 3 (PL, LDBC, and HDBC conditions, each 1 week with a 1-week washout between conditions) | Side-effects questionnaire assessing physical and psychological symptoms during each capsule condition (Placebo, Low-Dose Blackcurrant, and High-Dose Blackcurrant). |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as |
|---|---|
| Stroop Color-Word Test | Secondary outcome |
Source ConductCognition
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07853274
GET https://conductscience.org/api/trials/v1/NCT07853274/registered